Judge halts Royalty Pharma's bid for Elan stock

Royalty is a privately held New York company that buys royalty interests in drugs and late-stage drug candidates. It made an offer to buy Elan last month for $12.50 per share, or about $7.5 billion. Its offer was conditioned on shareholders rejecting an Elan push to refocus its… http://healthmedicinet.com/news/judge-halts-royalty-pharmas-bid-for-elan-stock/